Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Stem Cell Culture01:17

Stem Cell Culture

5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

1.7K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allergic Fungal Rhinosinusitis: Distinct Clinical Features, Diagnostic Challenges, and Evolving Therapeutic Strategies.

The journal of allergy and clinical immunology. In practice·2026
Same author

Oxygen Plasma Functionalization of Activated Carbon Pellets for Hazardous HCl Gas Mitigation: Balancing Surface Oxygenation and Pore Preservation.

Toxics·2026
Same author

Antegrade Versus Retrograde Facial Nerve Dissection in Benign Parotid Surgery: A Systematic Review and Meta-Analysis.

Head & neck·2026
Same author

Insight into the Impact of Wide Bandgap Transparent Conducting Oxide on the Performance of Thin Film Solar Cells.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Efficacy of stellate ganglion block for refractory sensorineural olfactory dysfunction: a systematic review and meta-analysis.

The Journal of laryngology and otology·2026
Same author

Efficacy of tezepelumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026

Related Experiment Video

Updated: Jun 25, 2025

Generation of Airway Epithelial Cell Air-Liquid Interface Cultures from Human Pluripotent Stem Cells
10:46

Generation of Airway Epithelial Cell Air-Liquid Interface Cultures from Human Pluripotent Stem Cells

Published on: June 14, 2022

4.2K

Tissue specific stem cell therapy for airway regeneration.

Dan Bi Park1, Jae Yoon Lee2, Sung Won Kim2

  • 1Postech-Catholic Biomedical Engineering Institute, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

Cell Proliferation
|May 28, 2024
PubMed
Summary

Secondary atrophic rhinitis (AR) research is advanced by a new animal model. Human stem cell therapy in this model showed promising ciliary regeneration, offering hope for effective treatments.

More Related Videos

Imaging-Guided Bioreactor for Generating Bioengineered Airway Tissue
11:01

Imaging-Guided Bioreactor for Generating Bioengineered Airway Tissue

Published on: April 6, 2022

2.6K
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.0K

Related Experiment Videos

Last Updated: Jun 25, 2025

Generation of Airway Epithelial Cell Air-Liquid Interface Cultures from Human Pluripotent Stem Cells
10:46

Generation of Airway Epithelial Cell Air-Liquid Interface Cultures from Human Pluripotent Stem Cells

Published on: June 14, 2022

4.2K
Imaging-Guided Bioreactor for Generating Bioengineered Airway Tissue
11:01

Imaging-Guided Bioreactor for Generating Bioengineered Airway Tissue

Published on: April 6, 2022

2.6K
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.0K

Area of Science:

  • Otorhinolaryngology
  • Regenerative Medicine
  • Biotechnology

Background:

  • Secondary atrophic rhinitis (AR) significantly impacts quality of life due to mucosal damage from nasal surgeries.
  • Current treatments for secondary AR are limited, highlighting the need for novel therapeutic strategies.
  • A scarcity of research on secondary AR impedes the development of effective interventions.

Purpose of the Study:

  • To develop a preclinical animal model that accurately replicates the histopathological features of secondary AR.
  • To evaluate the therapeutic potential of human nasal turbinate stem cells in treating secondary AR.

Main Methods:

  • Developed an animal model exhibiting key secondary AR histopathological changes: squamous metaplasia, goblet cell hyperplasia, submucosal fibrosis, and glandular atrophy.
  • Administered human nasal turbinate stem cells within a collagen type I hydrogel scaffold into the animal model.
  • Assessed therapeutic efficacy through observation of ciliary regeneration and other histopathological improvements.

Main Results:

  • The developed animal model successfully mimicked the characteristic histopathological alterations seen in human secondary AR.
  • Treatment with human nasal turbinate stem cells in collagen hydrogel resulted in significant ciliary regeneration.
  • The findings indicate a potential for cell-based therapies in restoring nasal mucosa.

Conclusions:

  • The novel animal model serves as a valuable platform for studying secondary AR pathogenesis and evaluating new treatments.
  • Human nasal turbinate stem cell therapy demonstrates therapeutic promise for secondary AR, particularly in promoting ciliary regeneration.
  • This approach offers a potential biotechnological intervention for improving outcomes in patients with secondary atrophic rhinitis.